Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Funding for innovative computational genomics and data science research to advance human health with focus on methodology development and scalability.
Browse similar grants
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | September 4, 2026 (Expiration) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $500,000 direct costs per year; maximum project period is 5 years; typical duration is 4–5 years depending on investigator status.
Summary: Supports innovative research in computational genomics, data science, statistics, and bioinformatics broadly applicable to human health and disease.
Description
This opportunity supports investigator-initiated research to advance computational genomics, data science, statistics, and bioinformatics, with a focus on developing innovative analytical methodologies, tools, and software that are broadly enabling for genomics and applicable across diseases and biological systems. The program aims to catalyze fundamental advances rather than incremental improvements or applications of existing approaches. Projects should address scalability to large datasets and promote generalizability. The funding opportunity is open to a wide range of applicants and encourages new investigators, those new to genomics, and underrepresented groups to apply.
